XCODE Life Sciences receives ISBA 2013 Promising Venture Award
Award presented in conjunction with the seventh edition of the Annual Incubator Conference on Business Incubation
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Archive
Lupin receives US FDA approval for SUPRAX oral suspension
The new dosage form will add to our growing SUPRAX franchise
GACL bags ‘Best Corporate Social Responsibility Practices’ award
YK Shishode, Public Relations Officer, GACL receives the award
Lupin gets US FDA nod for anxiety disorder drugs
Lorazepam oral concentrate had annual US sales of approximately $10.7 million
Compulsory Licensing: The Wild Card
If the recent recommendations of the Health Ministry are anything to go by, Compulsory Licensing (CL) might soon be a reality for…
Great Expectations from Budget 2013-14
This year's budget could very well prove to be a crucial and determining factor in the elections next year. The expectations are…
‘Time for a visionary budget’
2014 will be an election year where the people will decide who will be the government at the centre for the next five years. The…
’Need more focus towards taxes’
Diagnosis is an important aspect of the healthcare, which helps in detection, prevention and cure of disease. All life saving…
’How will the govt procure medicines worth Rs 27 cr?’
The pharma industry is looking for clarity on pricing mechanism. It would help to keep excise duty minimum. The current transfer…
’The proposal to set up a NLSRC by the DBT is a welcome suggestion’
AABLE is pleased to note that the emphasis on developing the S&T skills of the India are being taken seriously and that the…
’Aim to incentivise higher spending in R&D’
The economic and political developments in the Eurozone area and the US have affected the world economy including India. Although…
’Custom duty should be minimised, preferably eliminated’
For drug discovery and development, the scientists in pharma world need access to innovative tools like the latest analytical…
’A special focus on R&D funding is required’
It is critical for the country to improve its macro economic conditions in order to have a healthy industrial growth in near term.…
’Encourage R&D activity on clinical research front’
With a vision to establish India as a global centre for high quality, ethical contract research, ACRO India is continuously…
’GST on drugs must not result in higher tax’
The Government might finalise implementation date of GST and we expect the total tax rate for pharma industry to increase. To…
’We need to sustain significant growth process’
The last year has been a good year both on the domestic and foreign markets front and there is optimism that the industry will…
To poll or not to poll
Milind Sathe, Deputy General Manager-Projects, Unichem Laboratories, submits a qualitative analysis of responses to a recently…
Novartis Board of Directors and Dr Daniel Vasella agree to cancel non-compete agreement
The non-compete provided for an annual payout of up to CHF 12 million for six years, for a maximum total payout to Vasella of CHF…
India chapter of PSM advocates uniform standards for drugs with tracing and tracking system
PSM to launch a pilot project in India to enable patients to get their medicines tested